05/02/2016 17:24:47 1-888-992-3836 (toll free) Free Membership Login

Parexel News (NASDAQ:PRXL)

DateTimeSource
Headline
01/27/20164:05PMBWPAREXEL International Reports Second Quarter Fiscal Year 2016 Results
Adjusted earnings per share of $0.90, up 30.4%; GAAP diluted earnings per share of $0.73 Adjusted operating margin of 13.2%; GAAP operating margin of 10.5% Gross new business wins of $867 million; net book-to-bill ratio of 1.24; backlog at $5.5 billion Service revenue of $518.5 million, up 3.8%; constant currency revenue... More...>>
01/21/20169:30AMBWOptum & PAREXEL to Accelerate Drug Development, Reimbursement & Market Access with EHR-Fueled Clinical Research & Hybrid Stud...
Collaboration will focus on advancing drug development by combining clinical research and real-world evidence Optum and PAREXEL International (NASDAQ:PRXL) formed a strategic alliance to reduce drug development costs associated with post-approval studies, which are conducted after the approval of a product to obtain further... More...>>
01/19/201612:00PMBWPAREXEL Announces Execution of Definitive Agreement to Acquire Health Advances
Acquisition will strengthen PAREXEL’s Leadership in Strategic Consulting Services PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced that the Company has entered into a definitive agreement to acquire all outstanding equity securities of Health... More...>>
01/04/20169:00AMBWPAREXEL International to Present at JP Morgan Healthcare Conference
PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the JP Morgan Healthcare Conference on Wednesday, January 13, 2016, in San Francisco. Ingo Bank, Senior Vice President and Chief Financial Officer, will be making a presentation on PAREXEL and discussing business developments... More...>>
12/21/20158:00AMBWPAREXEL International Announces Date of Second Quarter Fiscal Year 2016 Earnings Release and Conference Call
PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for the Second Quarter Fiscal Year 2016 on Wednesday, January 27th, 2016 after the close of the stock market. PAREXEL will host a conference call and live webcast at 10:00 a.m. ET on Thursday, January 28th, 2016 to discuss the results. To access... More...>>
12/18/20159:00AMBWPAREXEL Wins Best Technological Development in Clinical Trial Award at the 11th Annual Scrip Awards
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, announced today that its Country Allocation Technology won the Best Technological Development in Clinical Trials Award at the 2015 Scrip Awards. The award recognizes the importance of PAREXEL’s Country Allocation Technology... More...>>
12/15/20159:00AMBWPAREXEL Informatics President Named a 2016 Computerworld Premier 100 Technology Leader
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, announced that IDG’s Computerworld named Xavier Flinois, President, PAREXEL Informatics, a 2016 Premier 100 Technology Leaders honoree. The Premier 100 spotlights 100 leaders in technology and business for their exceptional... More...>>
12/01/20159:00AMBWPAREXEL Launches IMPACT® Express Clinical Trial Management System
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today introduced IMPACT® Express Clinical Trial Management System (CTMS). IMPACT Express provides a quick-to-implement, cost-effective clinical trial management solution to simplify clinical trial management and monitoring... More...>>
11/23/20158:00AMBWPAREXEL International to Participate in ISI MedTools Summit
PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be attending the ISI MedTools Summit in Boston. Ingo Bank, Senior Vice President and Chief Financial Officer, will participate on Wednesday, December 2, 2015. About PAREXEL International PAREXEL International Corporation is a leading global biopharmaceutical... More...>>
11/17/20159:00AMBWPAREXEL Enhances End-to-End Clinical Development Services
New, dynamic technology-enabled processes offer sponsors speed and simplicity in study design, start-up, execution, and submission PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the enhancement of its end-to-end clinical development services through... More...>>
11/12/20159:00AMBWPAREXEL and Kyoto Pharmaceutical University Strengthen Commitment to Japan’s Biopharmaceutical Workforce
Joint Program for Clinical Research and Clinical Trial Management offered through the PAREXEL Academy PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, and Kyoto Pharmaceutical University (KPU), a private pharmacy and science university, today announced the new Joint... More...>>
11/09/20157:00AMBWPAREXEL Expands Market Access and Clinical Evidence Services
Greater emphasis on medical affairs, commercialization and lifecycle management for biopharmaceutical products PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced expanded evidence-based services for biopharmaceutical products. PAREXEL® Access focuses... More...>>
11/04/20158:00AMBWPAREXEL International to Present at Credit Suisse Healthcare Conference
PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Credit Suisse Healthcare Conference in Phoenix, AZ. Ingo Bank, Senior Vice President and Chief Financial Officer, will be making a presentation on PAREXEL and discuss business developments at 11:00 a.m. MST on Wednesday... More...>>
10/28/20154:01PMBWPAREXEL International Reports First Quarter Fiscal Year 2016 Results
First Quarter Fiscal Year 2016 Results (compared with First Quarter Fiscal Year 2015) Adjusted earnings per share of $0.70, up 7.7%; GAAP diluted earnings per share of $0.45 Adjusted operating margin of 10.8%; GAAP operating margin of 6.9% Gross new business wins of $914 million; net book-to-bill ratio of 1.19; backlog... More...>>
10/01/20159:00AMBWPAREXEL International Announces Date of First Quarter Fiscal Year 2016 Earnings Release and Conference Call
PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for the First Quarter Fiscal Year 2016 on Wednesday, October 28th, 2015 after the close of the stock market. The announcement will be available on PAREXEL’s website at www.PAREXEL.com. PAREXEL will host a conference call and live webcast... More...>>
09/23/20159:00AMBWPAREXEL’s Head of Learning and Development Named to 2015 PharmaVOICE 100 Most Inspiring People in the Life Sciences List
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, announced that PharmaVOICE named Albert Siu, PhD, Vice President, Learning and Development, PAREXEL, one of 2015’s PharmaVOICE 100 Most Inspiring People in the Life Sciences Industry. The honor, announced in the July/August... More...>>
09/17/20159:00AMBWPAREXEL International Announces $200 Million Accelerated Share Repurchase Program
PAREXEL International Corporation (Nasdaq: PRXL) announced today that it has entered into an Accelerated Share Repurchase (ASR) agreement with Wells Fargo Bank, National Association to repurchase an aggregate of $200 million of the Company’s common stock. The ASR is part of the Company’s share repurchase program authorizing... More...>>
09/14/20154:05PMPRNUSPAREXEL International Announces Stock Repurchase Program
PAREXEL International Announces Stock Repurchase Program PR Newswire BOSTON, Sept. 14, 2015 BOSTON, Sept. 14, 2015 /PRNewswire/ -- PAREXEL International Corporation (Nasdaq: PRXL) announced today that its Board of Directors has approved a stock repurchase program authorizing the repurchase of up to $200 million of the... More...>>
09/02/20159:00AMPRNUSPAREXEL International To Present At Wells Fargo Healthcare Conference And UBS Healthcare Supply Channel 1x1 Conference
PAREXEL International To Present At Wells Fargo Healthcare Conference And UBS Healthcare Supply Channel 1x1 Conference PR Newswire BOSTON, Sept. 2, 2015 BOSTON, Sept. 2, 2015 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) announced today that Ingo Bank, Senior Vice President and Chief Financial Officer... More...>>
08/26/20159:00AMPRNUSPAREXEL Names Maykin Ho to Board of Directors
PAREXEL Names Maykin Ho to Board of Directors PR Newswire BOSTON, Aug. 26, 2015 BOSTON, Aug. 26, 2015 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that its Board of Directors have elected Maykin Ho, Ph.D., to the Board, effective... More...>>


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:32 V:us D:20160205 22:24:49